Sterling Biotech Ltd has posted a net profit of Rs 216.29 million for the year ended December 31, 2002 as compared to a net profit of Rs 203.21 million for the year ended December 31, 2001. Total income has increased from Rs 1183.58 million in FY-01 to Rs 1896.78 million in FY-02.
It recommended a dividend of 12 per cent or Rs 0.24 a share of Rs 2 each, for the year ended December 31, 2002.
BSE code: 512299
